www.fdanews.com/articles/63313-with-fda-s-new-ok-for-avastin-genentech-says-it-will-cap-price
WITH FDA'S NEW OK FOR AVASTIN, GENENTECH SAYS IT WILL CAP PRICE
October 13, 2006
Genentech said Wednesday that U.S. regulators approved its cancer drug Avastin in combination with chemotherapy to treat lung cancer. The company also said it would cap the annual cost of the drug to some patients.
San Francisco Business Times (http://www.bizjournals.com/sanfrancisco/stories/2006/10/09/daily37.html)